At a glance
- Palmitoyl tripeptide-1 (pal-GHK) is the fatty-acid-anchored form of the GHK peptide, added to anti-aging serums and creams to support collagen and firmness.
- It is a signal peptide, or matrikine: the GHK sequence prompts skin cells to make more collagen and other matrix proteins, and the palmitoyl tail helps the water-loving peptide cross the skin's oily surface.
- Laboratory evidence for GHK is broad and consistent, but controlled studies of the palmitoylated form on real faces are scarce.
- The clearest human results come from combination products that pair it with palmitoyl tetrapeptide-7 and other actives, which makes its solo contribution hard to separate out.
- Evidence strength: Moderate, with strong cellular data for GHK and limited standalone clinical testing of the palmitoylated version.
What is palmitoyl tripeptide-1?
Palmitoyl tripeptide-1, often written pal-GHK, is a three-amino-acid peptide (glycyl-L-histidyl-L-lysine) with a palmitic acid chain attached. GHK occurs naturally in human plasma, declines with age, and has a long track record in wound-healing and tissue-repair research, as a 2024 review in BioImpacts describes. Its better-known relative is the copper complex GHK-Cu; the palmitoylated form swaps the copper for a fatty tail intended to help the peptide move through the skin's lipid barrier.
What skin type is palmitoyl tripeptide-1 best for?
It is aimed at people seeing early loss of firmness, fine lines, or thinning skin, and it suits most skin types because it is neither an acid nor a retinoid and rarely stings. Dry and sensitive skin usually tolerate it well. Anyone whose main concern is breakouts, oiliness, or active redness will do better with ingredients built for those problems.
What does palmitoyl tripeptide-1 do?
In cell and tissue studies, GHK signals fibroblasts to produce more collagen and glycosaminoglycans, and it has been linked to tissue regeneration, nerve outgrowth, and new blood-vessel formation. The palmitoyl tail is added to improve skin penetration, since the bare peptide is small and water-loving and does not cross the lipid barrier easily.
In a 12-week controlled trial of an eye cream that contained palmityl tripeptide-1 alongside palmitoyl tetrapeptide-7 and other actives, users saw measurable gains in skin collagen density, elasticity, and hydration, though the formula's other ingredients share the credit.
How do you know if palmitoyl tripeptide-1 can help your skin?
It is most likely to help if your goal is gradual support for firmness and fine lines rather than a dramatic change. Peptides work slowly, so give a product 8-12 weeks of steady use before judging it. Deep static wrinkles, sun damage, and volume loss respond far less to any topical peptide, and none of them match the effect of a retinoid or an in-office procedure.
How do you use palmitoyl tripeptide-1?
Apply it to clean skin, usually once or twice daily, most often in a serum or moisturizer. Follow with a moisturizer if the product is a lightweight serum, and use broad-spectrum sunscreen every morning, since sun protection does more to prevent new lines than any peptide. Consistency matters more than the amount you apply.
What should you use with palmitoyl tripeptide-1?
It layers well with hydrating and barrier-supporting ingredients such as hyaluronic acid, niacinamide, and ceramides, and it is often formulated beside other peptides. It is frequently paired with palmitoyl tetrapeptide-7 in the blend marketed as Matrixyl 3000, and the eye-cream trial above reflects that pairing. Daily sunscreen remains the most valuable partner in any routine built around firmness.
Evidence strength
Moderate: The GHK sequence has a large and consistent body of laboratory and cell-culture evidence for collagen support and tissue repair, as a 2024 review sets out. That same review notes a surprising absence of clinical studies on the palmitoylated and copper derivatives specifically, so much of the case for pal-GHK rests on the parent molecule and on cellular work.
The strongest human data come from a multi-ingredient eye cream trial, where the peptide's individual contribution cannot be isolated from the rest of the formula. Real-world results depend heavily on the product and its concentration.
References
- Mortazavi SM, Mohammadi Vadoud SA, Moghimi HR. Topically applied GHK as an anti-wrinkle peptide: Advantages, problems and prospective. BioImpacts. 2024. doi:10.34172/bi.30071
- Yang F, Zhang X, Wang H, et al. Comprehensive evaluation of the efficacy and safety of a new multi‐component anti‐aging topical eye cream. Skin Research and Technology. 2024;30(7):e13790. doi:10.1111/srt.13790
















